{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:46:56Z","timestamp":1792039616911,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012818","name":"Community of Madrid","doi-asserted-by":"publisher","award":["P2022\/BMD-7437"],"award-info":[{"award-number":["P2022\/BMD-7437"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Spanish Association Against Cancer Scientific Foundation","doi-asserted-by":"publisher","award":["RETOS245794PAZA"],"award-info":[{"award-number":["RETOS245794PAZA"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023479","name":"CRIS Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["INGENIO-PMP21\/00107"],"award-info":[{"award-number":["INGENIO-PMP21\/00107"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI22-01700"],"award-info":[{"award-number":["PI22-01700"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["AC20\/0070"],"award-info":[{"award-number":["AC20\/0070"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI23\/01557"],"award-info":[{"award-number":["PI23\/01557"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI23\/00198"],"award-info":[{"award-number":["PI23\/00198"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PMPTA22\/00167"],"award-info":[{"award-number":["PMPTA22\/00167"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI20\/00870"],"award-info":[{"award-number":["PI20\/00870"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008061","name":"Mutua Madrile\u00f1a Foundation","doi-asserted-by":"publisher","award":["AP18051-2022"],"award-info":[{"award-number":["AP18051-2022"]}],"id":[{"id":"10.13039\/100008061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.lungcan.2026.109609","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:49:13Z","timestamp":1788619753000},"page":"109609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Artificial Intelligence\u2013Based Assessment of Pathologic Response to Neoadjuvant Chemoimmunotherapy in Non\u2013Small Cell Lung Cancer: An International Multicenter Cohort Study"],"prefix":"10.1016","volume":"221","author":[{"given":"Daniel","family":"Curto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melina","family":"Peressini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Garcia-Lujan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Gamez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis Campo-Ca\u00f1averal","family":"de la Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"K\u00fcmpers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Matek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Elsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Steinestel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Martin-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Provencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Paz-Ares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Zugazagoitia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Lopez-Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Conde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.lungcan.2026.109609_b0005","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jtho.2024.06.010","article-title":"Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung Cancer","volume":"19","author":"Spicer","year":"2024","journal-title":"J Thorac Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109609_b0010","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/s43018-025-00990-7","article-title":"The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types","volume":"6","author":"Awada","year":"2025","journal-title":"Nat Cancer."},{"issue":"9","key":"10.1016\/j.lungcan.2026.109609_b0015","article-title":"Phase 3 Trials of Neoadjuvant, Perioperative, and Adjuvant Chemoimmunotherapy for Resectable, Early-Stage NSCLC: Comprehensive Review and Detailed Analysis","volume":"6","author":"Lee","year":"2025","journal-title":"JTO Clin Res Rep."},{"key":"10.1016\/j.lungcan.2026.109609_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108588","article-title":"Neoadjuvant immunotherapy in early-stage NSCLC: navigating biomarker dilemmas and special population challenges","volume":"204","author":"Chen","year":"2025","journal-title":"Lung Cancer."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109609_b0025","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41591-023-02660-6","article-title":"Association between pathologic response and survival after neoadjuvant therapy in lung cancer","volume":"30","author":"Deutsch","year":"2024","journal-title":"Nature Medicine."},{"key":"10.1016\/j.lungcan.2026.109609_b0030","article-title":"Pathological response in resectable non-small cell lung cancer: a systematic literature review and meta-analysis","volume":"8(3):pkae021","author":"Waser","year":"2024","journal-title":"JNCI Cancer Spectr."},{"key":"10.1016\/j.lungcan.2026.109609_b0035","article-title":"PT1.07.01 IASLC Multidisciplinary Recommendations for Pathological Response Evaluation of Resected Lymph Nodes After Neoadjuvant Therapy in NSCLC","volume":"20(10, Supplement 1):S600","author":"Berezowska","year":"2025","journal-title":"J Thorac Oncol."},{"key":"10.1016\/j.lungcan.2026.109609_b0040","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.lungcan.2021.02.014","article-title":"Controversies and challenges in the pathologic examination of lung resection specimens after neoadjuvant treatment","volume":"154","author":"Weissferdt","year":"2021","journal-title":"Lung Cancer."},{"issue":"5","key":"10.1016\/j.lungcan.2026.109609_b0045","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/PAP.0000000000000441","article-title":"Pathology of Surgically Resected Lung Cancers Following Neoadjuvant Therapy","volume":"31","author":"Berezowska","year":"2024","journal-title":"Adv Anat Pathol."},{"issue":"5","key":"10.1016\/j.lungcan.2026.109609_b0050","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jtho.2020.01.005","article-title":"IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy","volume":"15","author":"Travis","year":"2020","journal-title":"J Thorac Oncol."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109609_b0055","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1093\/annonc\/mdy218","article-title":"Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)","volume":"29","author":"Cottrell","year":"2018","journal-title":"Ann Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109609_b0060","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.annonc.2025.10.018","article-title":"Updated pan-tumor guidelines for neoadjuvant scoring of pathologic response: a joint SITC and INMC effort","volume":"37","author":"Deutsch","year":"2026","journal-title":"Ann Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2026.109609_b0065","article-title":"Assessing Pathologic Response in Resected Lung Cancers: Current Standards, Proposal for a Novel Pathologic Response Calculator Tool, and Challenges in Practice","volume":"3","author":"Saqi","year":"2022","journal-title":"JTO Clin Res Rep."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109609_b0070","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cllc.2019.11.003","article-title":"Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy","volume":"21","author":"Weissferdt","year":"2020","journal-title":"Clin Lung Cancer."},{"issue":"10","key":"10.1016\/j.lungcan.2026.109609_b0075","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jtho.2023.07.017","article-title":"International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy","volume":"18","author":"Dacic","year":"2023","journal-title":"J Thorac Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109609_b0080","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4143\/crt.2024.670","article-title":"Histological Assessment and Interobserver Agreement in Major Pathologic Response for Non-Small Cell Lung Cancer with Neoadjuvant Therapy","volume":"57","author":"Kim","year":"2025","journal-title":"Cancer Res Treat."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109609_b0085","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1158\/1078-0432.CCR-19-2379","article-title":"Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade","volume":"26","author":"Stein","year":"2020","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.lungcan.2026.109609_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2024.152268","article-title":"Comparison of different criteria for estimating major pathological response in resectable non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy","volume":"69","author":"Sun","year":"2024","journal-title":"Ann Diagn Pathol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109609_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100353","article-title":"Pathologic Processing of Lung Cancer Resection Specimens After Neoadjuvant Therapy","volume":"37","author":"Weissferdt","year":"2024","journal-title":"Mod Pathol."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109609_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.104122","article-title":"Is pathological response an adequate surrogate marker for survival in neoadjuvant therapy with immune checkpoint inhibitors?","volume":"10","author":"Sugiyama","year":"2025","journal-title":"ESMO Open."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109609_b0105","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.5858\/arpa.2024-0203-RA","article-title":"Neoadjuvant Therapy and Lung Cancer: Role of Pathologists","volume":"149","author":"Dacic","year":"2025","journal-title":"Arch Pathol Lab Med."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109609_b0110","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jtho.2021.03.029","article-title":"Evaluation of Pathologic Response in Lymph Nodes of Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy","volume":"16","author":"Pataer","year":"2021","journal-title":"J Thorac Oncol."},{"issue":"11","key":"10.1016\/j.lungcan.2026.109609_b0115","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1038\/s41379-021-00871-1","article-title":"Major pathologic response assessment and clinical significance of metastatic lymph nodes after neoadjuvant therapy for non-small cell lung cancer","volume":"34","author":"Liu","year":"2021","journal-title":"Mod Pathol."},{"key":"10.1016\/j.lungcan.2026.109609_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2024.05.009","article-title":"\u201cPercentage\u201d and \u201csize\u201d of residual viable tumor in lymph node, the performance in estimating pathologic response of lymph node in non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy","volume":"149","author":"Sun","year":"2024","journal-title":"Hum Pathol."},{"issue":"10","key":"10.1016\/j.lungcan.2026.109609_b0125","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.21037\/jtd-24-1011","article-title":"Pathological responses of primary tumor and lymph nodes in non-small cell lung cancer after neoadjuvant chemoimmunotherapy: a retrospective real-world study","volume":"16","author":"Shao","year":"2024","journal-title":"J Thorac Dis."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109609_b0130","article-title":"Prognostic significance of pathological response and lymph node status in neoadjuvant immunotherapy for potentially resectable non-small cell lung cancer","volume":"57","author":"Xu","year":"2025","journal-title":"Ann Med."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109609_b0135","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40164-023-00401-6","article-title":"\u201cMajor pathologic response\u201d in lymph nodes: a modified nodal classification for non-small cell lung cancer patients treated with neoadjuvant immunochemotherapy","volume":"12","author":"Deng","year":"2023","journal-title":"Exp Hematol Oncol."},{"issue":"9","key":"10.1016\/j.lungcan.2026.109609_b0140","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF01192200","article-title":"Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment","volume":"123","author":"Junker","year":"1997","journal-title":"J Cancer Res Clin Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2026.109609_b0145","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jtho.2023.12.010","article-title":"Artificial Intelligence-Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study","volume":"19","author":"Dacic","year":"2024","journal-title":"J Thorac Oncol."},{"issue":"11","key":"10.1016\/j.lungcan.2026.109609_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100302","article-title":"Deep Learning for Predicting Effect of Neoadjuvant Therapies in Non-Small Cell Lung Carcinomas With Histologic Images","volume":"36","author":"Terada","year":"2023","journal-title":"Mod Pathol."},{"key":"10.1016\/j.lungcan.2026.109609_b0155","doi-asserted-by":"crossref","unstructured":"Dacic S, Shenker D, Redman M, Brunner L, Saqi A, Cooper WA, Borczuk A, Chung JH, Glass C, Lopez JM, Roden AC, Sholl L, Weissferdt A, Brosnan-Cashman J, Hennek S, Grullon S, Posadas J, Fujimoto J, Connolly C, Wynes MW, Sanchez-Espiridion B, Lee JJ, Berezowska S, Chou TY, Kerr K, Nicholson AG, Schalper KA, Tsao MS, Ready N, Cascone T, Heymach J, Sepesi B, Shu C, Rizvi N, Sonett J, Altorki N, Provencio M, Bunn PA Jr, Kris MG, Travis W, Yu L, Wistuba I; IASLC Pathology Committee. Machine Learning Assessment of Pathologic Response in Lung Cancer Resections After Neoadjuvant Therapy-IASLC MPR Project. J Thorac Oncol. 2026 Jun 1:103953. doi: 10.1016\/j.jtho.2026.103953. . Epub ahead of print.","DOI":"10.1016\/j.jtho.2026.103953"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109609_b0160","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1186\/s12885-026-15885-8","article-title":"Diagnostic accuracy of an AI-based pathologic response assessment in locally advanced non-small cell lung cancer after neoadjuvant chemo-immunotherapy","volume":"26","author":"Lee","year":"2026","journal-title":"BMC Cancer."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109609_b0165","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jtho.2018.11.017","article-title":"Pathologic Assessment After Neoadjuvant Chemotherapy for NSCLC: Importance and Implications of Distinguishing Adenocarcinoma From Squamous Cell Carcinoma","volume":"14","author":"Qu","year":"2019","journal-title":"J Thorac Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109609_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2024.102166","article-title":"Concordance of Whole-Slide Imaging and Conventional Light Microscopy for Assessment of Pathologic Response Following Neoadjuvant Therapy for Lung Cancer","volume":"105","author":"Deutsch","year":"2025","journal-title":"Lab Invest."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109609_b0175","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/his.70025","article-title":"Pathologic assessment of resected stage III non-small cell lung cancer after neoadjuvant chemotherapy: identification of additional prognostic factors","volume":"88","author":"Lunardi","year":"2026","journal-title":"Histopathology."},{"issue":"7","key":"10.1016\/j.lungcan.2026.109609_b0180","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/s41379-021-00777-y","article-title":"A prognostic score for non-small cell lung cancer resected after neoadjuvant therapy in comparison with the tumor-node-metastases classification and major pathological response","volume":"34","author":"Zens","year":"2021","journal-title":"Mod Pathol."},{"issue":"5","key":"10.1016\/j.lungcan.2026.109609_b0185","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/JTO.0b013e318247504a","article-title":"Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy","volume":"7","author":"Pataer","year":"2012","journal-title":"J Thorac Oncol."},{"key":"10.1016\/j.lungcan.2026.109609_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108887","article-title":"Optimizing communication for ultrafast lung cancer biomarker testing: the UTOPIA pilot study","volume":"211","author":"Hernandez","year":"2026","journal-title":"Lung Cancer."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109609_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2026.101028","article-title":"Baseline Tumor Proliferation and Ki-67 Are Associated With Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-Small Cell Lung Cancer","volume":"39","author":"Wu","year":"2026","journal-title":"Mod Pathol."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109609_b0200","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/his.15550","article-title":"Current practice of pathologic response assessment following chemoimmunotherapy for non-small cell lung cancer (NSCLC) in Germany: first real-world data from the multicentre Re-GraDE study","volume":"87","author":"Elsner","year":"2025","journal-title":"Histopathology."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109609_b0205","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.annonc.2025.11.009","article-title":"ESMO basic requirements for AI-based biomarkers in oncology (EBAI)","volume":"37","author":"Aldea","year":"2026","journal-title":"Ann Oncol."},{"issue":"10","key":"10.1016\/j.lungcan.2026.109609_b0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0274091","article-title":"Epithelial cell size dysregulation in human lung adenocarcinoma","volume":"17","author":"Sandlin","year":"2022","journal-title":"PLoS One."},{"issue":"7","key":"10.1016\/j.lungcan.2026.109609_b0215","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.jtho.2024.03.010","article-title":"Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC","volume":"19","author":"Hines","year":"2024","journal-title":"J Thorac Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109609_b0220","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00428-024-03794-9","article-title":"Digital counting of tissue cells for molecular analysis: the QuANTUM pipeline","volume":"486","author":"L\u2019Imperio","year":"2025","journal-title":"Virchows Arch."},{"issue":"12","key":"10.1016\/j.lungcan.2026.109609_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100802","article-title":"Characterizing Interpretive and Diagnostic Competency Development in Pathology Training","volume":"38","author":"Bruny\u00e9","year":"2025","journal-title":"Mod Pathol."},{"issue":"10","key":"10.1016\/j.lungcan.2026.109609_b0230","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1038\/s41591-025-03953-8","article-title":"The STARD-AI reporting guideline for diagnostic accuracy studies using artificial intelligence","volume":"31","author":"Sounderajah","year":"2025","journal-title":"Nat Med."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109609_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100944","article-title":"Agreement Across 10 Artificial Intelligence Models in Assessing HER2 Expression in Breast Cancer Whole Slide Images","volume":"39","author":"McKelvey","year":"2026","journal-title":"Mod Pathol."},{"issue":"10","key":"10.1016\/j.lungcan.2026.109609_b0240","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.5858\/arpa.2023-0042-CP","article-title":"Recommendations for Performance Evaluation of Machine Learning in Pathology: A Concept Paper From the College of American Pathologists","volume":"148","author":"Hanna","year":"2024","journal-title":"Arch Pathol Lab Med."},{"issue":"12","key":"10.1016\/j.lungcan.2026.109609_b0245","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/s41379-022-01167-8","article-title":"Rethinking the role of biomarkers for operable non-small cell lung carcinoma: an effective collaboration with artificial intelligence algorithms","volume":"35","author":"Conde","year":"2022","journal-title":"Mod Pathol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:10:21Z","timestamp":1792037421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226006707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":49,"alternative-id":["S0169500226006707"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109609","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial Intelligence\u2013Based Assessment of Pathologic Response to Neoadjuvant Chemoimmunotherapy in Non\u2013Small Cell Lung Cancer: An International Multicenter Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109609","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109609"}}